350 related articles for article (PubMed ID: 20493842)
21. Presentation of Toxoplasma gondii antigens via the endogenous major histocompatibility complex class I pathway in nonprofessional and professional antigen-presenting cells.
Dzierszinski F; Pepper M; Stumhofer JS; LaRosa DF; Wilson EH; Turka LA; Halonen SK; Hunter CA; Roos DS
Infect Immun; 2007 Nov; 75(11):5200-9. PubMed ID: 17846116
[TBL] [Abstract][Full Text] [Related]
22. CD4-mediated and CD8-mediated cytotoxic and proliferative immune responses to Toxoplasma gondii in seropositive humans.
Purner MB; Berens RL; Nash PB; van Linden A; Ross E; Kruse C; Krug EC; Curiel TJ
Infect Immun; 1996 Oct; 64(10):4330-8. PubMed ID: 8926107
[TBL] [Abstract][Full Text] [Related]
23. Leishmania antigens are presented to CD8+ T cells by a transporter associated with antigen processing-independent pathway in vitro and in vivo.
Bertholet S; Goldszmid R; Morrot A; Debrabant A; Afrin F; Collazo-Custodio C; Houde M; Desjardins M; Sher A; Sacks D
J Immunol; 2006 Sep; 177(6):3525-33. PubMed ID: 16951311
[TBL] [Abstract][Full Text] [Related]
24. Activation of CD4+ and CD8+ parasite -specific T-cells by macrophages infected with live T. cruzi amastigotes.
Caulada-Benedetti Z; Vecchio LC; Pardi CC; Massironi SM; D'Império Lima MR; Abrahamsohn IA
Immunol Lett; 1998 Sep; 63(2):97-105. PubMed ID: 9761371
[TBL] [Abstract][Full Text] [Related]
25. Trypanosoma cruzi down-regulates lipopolysaccharide-induced MHC class I on human dendritic cells and impairs antigen presentation to specific CD8(+) T lymphocytes.
Van Overtvelt L; Andrieu M; Verhasselt V; Connan F; Choppin J; Vercruysse V; Goldman M; Hosmalin A; Vray B
Int Immunol; 2002 Oct; 14(10):1135-44. PubMed ID: 12356679
[TBL] [Abstract][Full Text] [Related]
26. IL-12 signaling drives CD8+ T cell IFN-gamma production and differentiation of KLRG1+ effector subpopulations during Toxoplasma gondii Infection.
Wilson DC; Matthews S; Yap GS
J Immunol; 2008 May; 180(9):5935-45. PubMed ID: 18424713
[TBL] [Abstract][Full Text] [Related]
27. Coinfection with Heligmosomoides polygyrus fails to establish CD8+ T-cell immunity against Toxoplasma gondii.
Khan IA; Hakak R; Eberle K; Sayles P; Weiss LM; Urban JF
Infect Immun; 2008 Mar; 76(3):1305-13. PubMed ID: 18195022
[TBL] [Abstract][Full Text] [Related]
28. CD8+ T cells in Trypanosoma cruzi infection.
Tarleton RL
Semin Immunopathol; 2015 May; 37(3):233-8. PubMed ID: 25921214
[TBL] [Abstract][Full Text] [Related]
29. Trypanosoma cruzi: protective response of vaccinated mice is mediated by CD8+ cells, prevents signs of polyclonal T lymphocyte activation, and allows restoration of a resting immune state after challenge.
Paiva CN; Castelo-Branco MT; Lannes-Vieira J; Gattass CR
Exp Parasitol; 1999 Jan; 91(1):7-19. PubMed ID: 9920038
[TBL] [Abstract][Full Text] [Related]
30. Strain- and Dose-Dependent Reduction of
Jennes M; De Craeye S; Devriendt B; Dierick K; Dorny P; Cox E
Front Cell Infect Microbiol; 2017; 7():232. PubMed ID: 28642841
[No Abstract] [Full Text] [Related]
31. Limited role for CD4+ T-cell help in the initial priming of Trypanosoma cruzi-specific CD8+ T cells.
Padilla A; Xu D; Martin D; Tarleton R
Infect Immun; 2007 Jan; 75(1):231-5. PubMed ID: 17043105
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of cellular invasion by intracellular parasites.
Walker DM; Oghumu S; Gupta G; McGwire BS; Drew ME; Satoskar AR
Cell Mol Life Sci; 2014 Apr; 71(7):1245-63. PubMed ID: 24221133
[TBL] [Abstract][Full Text] [Related]
33. An immunoinformatic approach for identification of Trypanosoma cruzi HLA-A2-restricted CD8(+) T cell epitopes.
Eickhoff CS; Van Aartsen D; Terry FE; Meymandi SK; Traina MM; Hernandez S; Martin WD; Moise L; De Groot AS; Hoft DF
Hum Vaccin Immunother; 2015; 11(9):2322-8. PubMed ID: 26107442
[TBL] [Abstract][Full Text] [Related]
34. Paraflagellar rod protein-specific CD8+ cytotoxic T lymphocytes target Trypanosoma cruzi-infected host cells.
Wrightsman RA; Luhrs KA; Fouts D; Manning JE
Parasite Immunol; 2002 Aug; 24(8):401-12. PubMed ID: 12406194
[TBL] [Abstract][Full Text] [Related]
35. Limited Foxp3
Araujo Furlan CL; Tosello Boari J; Rodriguez C; Canale FP; Fiocca Vernengo F; Boccardo S; Beccaria CG; Adoue V; Joffre O; Gruppi A; Montes CL; Acosta Rodriguez EV
Front Immunol; 2018; 9():2555. PubMed ID: 30455700
[TBL] [Abstract][Full Text] [Related]
36. CD8+ T cells in Trypanosoma cruzi infection.
Padilla AM; Bustamante JM; Tarleton RL
Curr Opin Immunol; 2009 Aug; 21(4):385-90. PubMed ID: 19646853
[TBL] [Abstract][Full Text] [Related]
37. Stable CD8+ T cell memory during persistent Trypanosoma cruzi infection.
Bixby LM; Tarleton RL
J Immunol; 2008 Aug; 181(4):2644-50. PubMed ID: 18684955
[TBL] [Abstract][Full Text] [Related]
38. Vaccine development against Trypanosoma cruzi and Leishmania species in the post-genomic era.
Dumonteil E
Infect Genet Evol; 2009 Dec; 9(6):1075-82. PubMed ID: 19805015
[TBL] [Abstract][Full Text] [Related]
39. CD8+ T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes.
Martin DL; Weatherly DB; Laucella SA; Cabinian MA; Crim MT; Sullivan S; Heiges M; Craven SH; Rosenberg CS; Collins MH; Sette A; Postan M; Tarleton RL
PLoS Pathog; 2006 Aug; 2(8):e77. PubMed ID: 16879036
[TBL] [Abstract][Full Text] [Related]
40. Long-Term Immunity to Trypanosoma cruzi in the Absence of Immunodominant trans-Sialidase-Specific CD8+ T Cells.
Rosenberg CS; Zhang W; Bustamante JM; Tarleton RL
Infect Immun; 2016 Sep; 84(9):2627-38. PubMed ID: 27354447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
